• 2 累計(jì)需求單數(shù)
        ¥50.0 累計(jì)需求金額
        0 違規(guī)次數(shù)

        需要下載2篇外文文獻(xiàn)

        懸賞
        已托管
        50.00
        ¥50.00
        1. 發(fā)布需求
        2. 藥智客交稿
        3. 任務(wù)主選稿中
        4. 驗(yàn)收與付款
        已退款
        交易模式:
        單人中標(biāo)
        賞金分配:
        一人獨(dú)享賞金,¥42.5
        具體要求:
        1.Title:Studies of the polymorphism of sodium valproate. (Ger.). Authors:Kleinebudde P; Thies R Publication Name:Sci.Pharm. Publication Year:1999 Keywords:Valproate Sodium/Oc Crystal/Ft Polymorphism/Ft Calorimetry/Ft X-Ray- Diffraction/Ft Analysis/Ft Crystallography/Ft Anticonvulsants/Ft Antimanics / Ft Oc / Ft Extract:2 Crystal modifications (M1 and M2) of Na valproate (NV) have been detected at RT, while a further form (M3) occurred at temperatures above 100 deg. Untreated NV, which had been recrystallized from toluene or ethyl acetate occurred as modification M1. These modifications were examined by thermoanalytical (DSC, thermogravimetry) and X-ray crystallographic methods. 2.【題名】Polymorphism of sodium valproate 【作 者】Mifsud, H.;Miguel, L.;Lavastre, V.;Maire, G. 【刊 名】Calorim. Anal. Therm. Calorimetrie et Analyse Thermique 【出版日期】1993 【卷 號】Vol.24 【頁 碼】309-312 【關(guān)鍵詞】polymorphism sodium valproate Polymorphism of sodium valproate 1069-66-5 polymorphism 【摘 要】Polymorphism anal. is of fundamental pharmaceutical importance for correct development of a drug, as it provides valuable knowledge of its biopharmaceutical and technol. aspects. Indeed, different polymorphs exhibit different phys. properties that can affect bioavailability. Polymorphism screening has been developed in the authors' lab., based on crystn. parameter variations for a given drug in soln. Sodium valproate is an anti-epileptic drug commercialized under the name Depakine. Five polymorphic forms were obtained by the screening and characterized by differential scanning calorimetry, X-ray powder diffractometry, thermogravimetry and IR spectroscopy. The relationships between these forms were examd.
        2020-08-26 16:54
        0條新稿件,點(diǎn)擊看看
        • 匿名

          能否附上鏈接

          2020-08-28 11:46 IP:東莞 參與編號 # 舉報(bào)
          發(fā)言請遵守"七條底線",還可以輸入140個字

        當(dāng)前為付費(fèi)需求,賞金分配方式:一人獨(dú)享賞金。

        任務(wù)主在眾多備選稿件中選擇最滿意的稿件,支付賞金。

        托管賞金,保障各方權(quán)益:

        任務(wù)主把所發(fā)需求的懸賞金托管到藥智網(wǎng)指定賬戶,以激發(fā)眾多藥智客的參與熱情,保障任務(wù)主盡快征集到滿意稿件;

        同時,賞金托管也是為了保障參與挑戰(zhàn)的藥智客的正當(dāng)權(quán)益。

        流程說明:

        發(fā)布需求

        點(diǎn)擊“發(fā)布需求”按鈕,按照流程引導(dǎo),將需求詳情、具體要求描述清楚,發(fā)布到藥智網(wǎng)的藥智匯平臺。

        托管賞金

        為征集到滿意稿件,任務(wù)主須做好“賞金預(yù)算”,并將賞金托管到藥智網(wǎng)指定賬戶,打消藥智客的顧慮,激勵藥智客積極參與需求挑戰(zhàn)。

        藥智客參與

        任務(wù)主托管賞金后,所發(fā)布的需求顯示“賞金已托管”字樣。只有托管了懸賞金的需求,能夠鼓舞眾多的藥智客參與,獲取到滿意的稿件!

        選擇滿意稿件

        任務(wù)主在眾多參與者提交的稿件中,選擇符合任務(wù)主需求的稿件。再通過互動,選擇任務(wù)主最滿意的稿件,并確定其為中標(biāo)稿件。

        驗(yàn)收與付款

        中標(biāo)稿件提交任務(wù)主驗(yàn)收。任務(wù)主在驗(yàn)收/驗(yàn)證期內(nèi),完成驗(yàn)收/驗(yàn)證工作。對合格稿件,通知藥智網(wǎng)支付傭金。

        評價

        雙方可以針對本次交易各自的表現(xiàn)進(jìn)行評價,評價結(jié)果將影響各自的信用度和能力值。

        類似的需求

          加載數(shù)據(jù)中...

        該需求者還有這些需求

          加載數(shù)據(jù)中...

        推薦需求

          加載數(shù)據(jù)中...
        感興趣,就投稿吧!投的越早,中標(biāo)幾率就越大! 收藏
        挖掘醫(yī)藥數(shù)據(jù),分享醫(yī)藥情報(bào)
        掃一掃,關(guān)注藥智數(shù)據(jù)公眾號

        2014 藥智再發(fā)力 我們換裝了?。?/p>

        為了讓您有更好的體驗(yàn),藥智對用戶體系和產(chǎn)品進(jìn)行了全新升級!

        我要看看
        久碰是精品香蕉频线观,欧美 亚洲 日韩 精品 国产,av五月天 在线,六月婷婷国外视频在线 中日韩va无码中文字幕 午夜无码片在线观看线